CVR: 35240446
Previous names: COVANCE DENMARK ApS, Labcorp Clinical Development ApS
Fortrea Denmark ApS is a Danish company of the type Anpartsselskab based in Søborg, founded in 2013. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Labcorp Clinical Development ApS and COVANCE DENMARK ApS. The management consists of Agnieszka Moskal Gallagher. The company is owned by Fortrea Development Ltd.. The company has 43 employees. In 2025, the company reported a gross profit of DKK 29,191,545 and a net result of DKK 1,739,960 compared with DKK 688,702 the year before. Equity amounted to DKK 10,187,341.
Your company? Claim the profile and show your logo, website and social channels — for free.
Claim this profileSelskabets formål er at levere tjenesteydelser i forbindelse med udvikling af nye lægemidler samt dermed beslægtet virksomhed.
| Year | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | 29.2 mio. | 1.7 mio. | 37.3 mio. | 10.2 mio. | 33 | |
| 2024 | 31.6 mio. | 689 t. | 10.5 mio. | 8.4 mio. | 38 | |
| 2023 | 37.8 mio. | 1.6 mio. | 14 mio. | 7.8 mio. | 41 | |
| 2022 | 40.9 mio. | 3.2 mio. | 10.5 mio. | 6.1 mio. | 41 | |
| 2021 | 38.9 mio. | 2.7 mio. | 7.1 mio. | 2.9 mio. | 43 | |
| 2020 | 40.4 mio. | 3 mio. | 20.4 mio. | 10.7 mio. | 46 | |
| 2019 | 35.9 mio. | 2.5 mio. | 13.5 mio. | 7.7 mio. | 43 | |
| 2018 | 34.4 mio. | 2.5 mio. | 11 mio. | 5.2 mio. | 41 | |
| 2017 | 33.7 mio. | 2.6 mio. | 16.1 mio. | 10.7 mio. | 40 | |
| 2016 | 33 mio. | 2.5 mio. | 12.9 mio. | 8.1 mio. | 39 | |
| 2015 | 26.2 mio. | 1.9 mio. | 10 mio. | 5.6 mio. | - | |
| 2014 | 23.3 mio. | 1.7 mio. | 8 mio. | 3.7 mio. | - |
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreCompared to 1.052 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Fortrea Denmark ApS has published its annual report for 2025. Gross profit came to DKK 29,191,545, and the net result was DKK 1,739,960.
Contact info changed: new phone: 36440400 (January 21, 2026).
As of December 31, 2025, Agnieszka Moskal Gallagher is registered as director of Fortrea Denmark ApS.
As of December 31, 2025, James Stillman Hanson has stepped down as director of Fortrea Denmark ApS.
Fortrea Denmark ApS has published its annual report for 2024. Gross profit came to DKK 31,590,826, and the net result was DKK 688,702.
As of August 16, 2024, James Stillman Hanson is registered as director of Fortrea Denmark ApS.
As of August 16, 2024, Amedeo Joseph De Risi has stepped down as director of Fortrea Denmark ApS.
Fortrea Denmark ApS has published its annual report for 2023. Gross profit came to DKK 37,846,930, and the net result was DKK 1,637,713.
As of June 22, 2023, Amedeo Joseph De Risi is registered as director of Fortrea Denmark ApS.
As of June 22, 2023, Robert Stewart Pringle has stepped down as director of Fortrea Denmark ApS.
Fortrea Denmark ApS has published its annual report for 2022. Gross profit came to DKK 40,948,646, and the net result was DKK 3,183,261.
On May 1, 2023, the company changed its name from Labcorp Clinical Development ApS to Fortrea Denmark ApS.
Fortrea Denmark ApS has published its annual report for 2021. Gross profit came to DKK 38,944,351, and the net result was DKK 2,697,754.
On June 25, 2021, the company changed its name from COVANCE DENMARK ApS to Labcorp Clinical Development ApS.
Fortrea Denmark ApS has published its annual report for 2020. Gross profit came to DKK 40,435,500, and the net result was DKK 3,019,056.
Fortrea Denmark ApS has published its annual report for 2019. Gross profit came to DKK 35,918,507, and the net result was DKK 2,544,529.
Fortrea Denmark ApS has published its annual report for 2018. Gross profit came to DKK 34,373,058, and the net result was DKK 2,476,905.
Fortrea Denmark ApS has published its annual report for 2017. Gross profit came to DKK 33,686,930, and the net result was DKK 2,615,081.
As of March 31, 2018, Robert James Davie has stepped down as director of Fortrea Denmark ApS.
Fortrea Denmark ApS has published its annual report for 2016. Gross profit came to DKK 33,032,100, and the net result was DKK 2,458,100.
As of May 25, 2016, Beierholm Godkendt Revisionspartnerselskab has been appointed auditor of Fortrea Denmark ApS.
As of May 25, 2016, RSM PLUS P/S STATSAUTORISEREDE REVISORER has stepped down as auditor of Fortrea Denmark ApS.
Fortrea Denmark ApS has published its annual report for 2015. Gross profit came to DKK 26,249,247, and the net result was DKK 1,923,117.
Fortrea Denmark ApS has published its annual report for 2014. Gross profit came to DKK 23,337,358, and the net result was DKK 1,697,507.
As of March 13, 2015, RSM PLUS P/S STATSAUTORISEREDE REVISORER has been appointed auditor of Fortrea Denmark ApS.
As of March 13, 2015, BDO Holding VII, statsautoriseret revisionsaktieselskab has stepped down as auditor of Fortrea Denmark ApS.
Fortrea Denmark ApS has published its interim report for the period May 8, 2013 – December 31, 2013.
As of May 8, 2013, BDO Holding VII, statsautoriseret revisionsaktieselskab has been appointed auditor of Fortrea Denmark ApS.
As of May 8, 2013, Robert Stewart Pringle is registered as director of Fortrea Denmark ApS.
As of May 8, 2013, Robert James Davie is registered as director of Fortrea Denmark ApS.
As of May 8, 2013, is registered as an owner of Fortrea Denmark ApS with an ownership share of 100%.
Fortrea Denmark ApS was founded on May 8, 2013.
Companies in the same industry and area
CVR 45943062
CVR 41093447
CVR 37918806
CVR 39119374
CVR 42653276
companydata.dk